Drug Search Results
More Filters [+]

QP-001

Alternative Names: qp-001, qp 001, qp001
Latest Update: 2023-10-01
Latest Update Note: PubMed Publication

Product Description

For moderate to severe pain after abdominal surgery (Sourced from: https://www.chictr.org.cn/showprojen.aspx?proj=135457)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Center for Clinical Pharmacology, the Third Xiangya Hospital, Central South University
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for QP-001

Countries in Clinic: China

Active Clinical Trial Count: 4

Highest Development Phases

Phase 3: Abdominal Pain|Pain Unspecified

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20212481

P2

Completed

Abdominal Pain

2022-04-09

CTR20211452

P1

Not yet recruiting

Healthy Volunteers|Pain Unspecified

None

CTR20222580

P3

Not yet recruiting

Pain Unspecified

None

CTR20222714

P3

Not yet recruiting

Abdominal Pain

None

Recent News Events